StockNews.com assumed coverage on shares of Vericel ( NASDAQ:VCEL – Get Rating ) in a report released on Thursday. The brokerage issued a hold rating on the biotechnology company's stock. Other analysts have also issued research reports about the company. Stephens raised their target price on Vericel from $39.00 to $42.00 in a report on Thursday, May 11th. HC Wainwright reaffirmed a buy rating and issued a $37.00 target price on shares of Vericel in a report on Friday, January 27th. Finally, Truist Financial raised their target price on Vericel from $31.

https://www.dailypolitical.com/2023/05/21/vericel-nasdaqvcel-coverage-initiated-by-analysts-at-stocknews-com.html

#dailypolitical